Kitazato Corporation (368A) Balance sheet

Market cap
¥48B
P/E ratio
12.1x
Kitasato Corporation develops and manufactures medical devices and reagents for reproductive medicine including IVF and egg freezing, serving hospitals and clinics in over 110 countries worldwide.
2022/032023/032024/032025/032026/03
Cash and cash equivalents -8,09910,50411,46013,414
Inventories-321342388399
Total current assets-11,36313,71114,83517,147
Property, plant and equipment, net-3,7713,7644,5524,582
Total non-current assets-4,1384,1454,9134,849
Total assets -15,50117,85719,74821,996
Total current liabilities-1,3131,6751,4191,430
Total non-current liabilities-1011217961
Total liabilities -1,4141,7961,4991,491
Retained earnings-14,07716,05018,23920,494
Stockholders' equity11,91614,08716,06018,24920,504
AI Chat